AGP Picks
View all

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

Press releases published on August 12, 2026

ADARx Pharmaceuticals Expands Leadership Team with Board and Executive Appointments
Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
Altimmune Announces Second Quarter 2026 Financial Results and Business Update
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update
Nova Minerals Provides an Update on Its 2026 Field Season Activities
Titan Mining Reports 57% Revenue Growth and Nearly 4x Adjusted EBITDA
MEXC First to List Unitree Pre-IPO Futures as Daily Trading Volume Surges 1,104%
MEXC Introduces 31 New 0-Fee Stock and ETF Futures Across Key Market Sectors
MEXC's July Highlights: Stock Futures Volume Up 111%, Tokenized Equities Take 62% of TradFi Spot
Rakovina Therapeutics Announces Closing of First Tranche, Upsize and Extension of Non-Brokered Private Placement
ダーク・ホース・コンサルティング・グループが中国に進出、カン・リウをシニアディレクター兼中国事業責任者に任命
다크호스 컨설팅 그룹, 중국 시장 진출하며 강 리우 중국사업 총괄 수석이사 선임
Dark Horse Consulting Group Meluaskan Operasi ke China, Melantik Kang Liu sebagai Pengarah Kanan dan Ketua China
Dark Horse Consulting Group 进军中国市场,任命 Kang Liu 为高级总监兼中国区负责人
Dark Horse Consulting Group 拓展中國市場,任命 Kang Liu 為高級總監兼中國區負責人

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Africa Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.